Qualigen Therapeutics Inc (QLGN) stock is lower by -21.90% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives QLGN stock a score of 5 out of a possible 100.
That rank is mainly influenced by a fundamental score of 0. QLGN stock has a mean target price of 10. This means analysts expect the stock to gain 143.90% over the next 12 months. QLGN's rank also includes a short-term technical score of 6. The long-term technical score for QLGN is 9.
What's Happening with QLGN Stock Today
Qualigen Therapeutics Inc (QLGN) stock has fallen -3.1% while the S&P 500 is lower by -0.09% as of 1:38 PM on Tuesday, Feb 9. QLGN is lower by -$0.13 from the previous closing price of $4.23 on volume of 4,883,165 shares. Over the past year the S&P 500 has gained 16.70% while QLGN is lower by -21.90%. QLGN lost -$4.68 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Qualigen Therapeutics Inc (QLGN) Stock.
